Analysts review Recursion Pharmaceuticals Inc’s rating

Recursion Pharmaceuticals Inc’s recently made public that its Chief Executive Officer Gibson Christopher unloaded Company’s shares for reported $0.36 million on Apr 04 ’24. In the deal valued at $9.02 per share,40,000 shares were sold. As a result of this transaction, Gibson Christopher now holds 938,524 shares worth roughly $8.45 million. Then, Gibson Christopher sold […]

RXRX’s short interest surges to 43.52 million shares

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Recursion Pharmaceuticals Inc shares valued at $100,942 were sold by Borgeson Blake on Apr 02 ’24. At $8.82 per share, Borgeson Blake sold 11,447 shares. The insider’s holdings dropped to 7,241,308 shares worth approximately […]

RXRX’s Chief Executive Officer, Gibson Christopher, sellss 40,000 shares.

Recursion Pharmaceuticals Inc’s recent filing unveils that its Chief Executive Officer Gibson Christopher unloaded Company’s shares for reported $0.4 million on Mar 28 ’24. In the deal valued at $10.10 per share,40,000 shares were sold. As a result of this transaction, Gibson Christopher now holds 1,043,524 shares worth roughly $9.78 million. Then, Gibson Christopher sold […]